The Velindre University NHS Trust is an NHS Wales trust established in 1994 as a specialist provider of cancer services in Wales. It runs the Velindre Cancer Centre and the Welsh Blood Service.

During the past decade, Velindre NHS Trust conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Velindre NHS Trust" #1 sponsor was "AstraZeneca" with 1 trials, followed by "Clovis Oncology, Inc." with 1 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Institute of Cancer Research, United Kingdom" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Velindre NHS Trust" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Advaxis, Inc." with 1 trials as a collaborator, "AdventHealth" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Velindre NHS Trust" are "Fallopian Tube Cancer" (2 trials), "Malignant Melanoma" (2 trials), "Ovarian Cancer" (2 trials), "Peritoneal Cancer" (2 trials) and "Epithelial Ovarian Cancer" (1 trials). Many other conditions were trialed in "Velindre NHS Trust" in a lesser frequency.

Most popular intervention types in "Velindre NHS Trust" are "Drug" (8 trials), "Biological" (5 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (2 trials), "Fulvestrant" (2 trials), "Nivolumab" (2 trials), "Placebo" (2 trials) and "ADXS11-001" (1 trials). Other intervention names were less common.

The vast majority of trials in "Velindre NHS Trust" are 7 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Velindre NHS Trust". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Velindre NHS Trust, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Velindre NHS Trust, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".